跳至主要内容
临床试验/NCT03234452
NCT03234452已完成不适用

Evaluation of the Beneficial Effects of a Probiotic Product (Lactoflorene Plus) in Healthy Adult Subjects in Particular Psychological Stress Conditions.

Montefarmaco OTC SpA2 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2016年3月23日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
50
试验地点
2
主要终点
NK activity

研究概览

简要总结

A randomized, double-blind, placebo-controlled, cross-over trial performed at one centre in Italy to explore the ability of a multistrain probiotic mixture, to modulate markers of inflammation and intestinal barrier function and gastrointestinal symptoms in healthy volunteers with self-reported anxiety.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

盲法说明

double-blind

入排标准

年龄范围
20 Years 至 35 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Eligible subjects were healthy men and women, 20-35 years old, with a STAI scale, form Y, module 1 (state anxiety) score of ≥ 35 and ≥40, for men and women, respectively.

排除标准

  • Most important exclusion criteria were history or diagnosis of GI disease, oral antibiotics within 30 days prior to the screening visit, and use of drugs, food or herbal supplements for digestive symptoms.

研究组 & 干预措施

Lactoflorene plus

Experimental

10 ml mixture of Lactobacillus acidophilus LA-5®, Bifidobacterium animalis subsp. lactis, BB-12®, Lactobacillus paracasei subsp. paracasei, L. CASEI 431® , Bacillus coagulans BC513, zinc and B-vitamins (niacin, B1, B2, B5, B6, B12 and folic acid) twice a day

干预措施: Lactoflorene plus (Dietary Supplement)

Placebo Lactoflorene plus

Placebo Comparator

Identical placebo mixture without probiotics, B-vitamins and zinc. The active and placebo products had similar appearance, taste and smell and were provided in identical bottles of 10 ml with identical labelling.

干预措施: Placebo Lactoflorene plus (Dietary Supplement)

结局指标

主要结局

NK activity

时间窗: 45 days

Verify that Natural Killer activities concentration is significantly higher in the experimental Group compared to the placebo group

次要结局

  • microbiota composition investigation(45 days)
  • Cortisol, alpha-amylase , chromogranin A(45 days)
  • IgA, IL8, TNF-Alpha, IL10(45 days)
  • Gastrointestinal symptoms (abdominal pain, aerophagia, diarrhea, constipation, diarrhea/constipation alternation )(45 days)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Evaluation of the Beneficial Effects of a Probiotic... | 临床试验